针对新冠病毒感染的肺部免疫反应：有害与否？ - Suppr

Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?

作者信息

Guillon A, Hiemstra P S, Si-Tahar M

机构信息

Intensive Care Unit, Tours University Hospital, 2 Bd Tonnellé, 37044, Tours Cedex 9, France.

University of Tours, Tours, France.

出版信息

Intensive Care Med. 2020 Oct;46(10):1897-1900. doi: 10.1007/s00134-020-06170-8. Epub 2020 Jul 17.

DOI:10.1007/s00134-020-06170-8

PMID:32681297

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7366461/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b291/7366461/3e36347bb6f9/134_2020_6170_Fig1_HTML.jpg

相似文献

Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?

Intensive Care Med. 2020 Oct;46(10):1897-1900. doi: 10.1007/s00134-020-06170-8. Epub 2020 Jul 17.

Sex-biased Immune Responses Following SARS-CoV-2 Infection.

Trends Microbiol. 2020 Dec;28(12):952-954. doi: 10.1016/j.tim.2020.10.002. Epub 2020 Oct 10.

Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections.

Front Immunol. 2020 Aug 18;11:1979. doi: 10.3389/fimmu.2020.01979. eCollection 2020.

A Commentary on "A comparative overview of COVID-19, MERS and SARS: Review article" (International Journal of Surgery 2020; 81:1-8).

Int J Surg. 2020 Nov;83:28-29. doi: 10.1016/j.ijsu.2020.08.049. Epub 2020 Sep 11.

[Analysis of coronavirus disease-19 (COVID-19) based on SARS autopsy].

Zhonghua Bing Li Xue Za Zhi. 2020 Apr 8;49(4):291-293. doi: 10.3760/cma.j.cn112151-20200211-00114.

Is SARS-CoV-2 Serology Relevant for Hemodialysis Patients With COVID-19?

Am J Kidney Dis. 2020 Oct;76(4):598. doi: 10.1053/j.ajkd.2020.06.006. Epub 2020 Jun 27.

A comparative overview of COVID-19, MERS and SARS: Review article.

Int J Surg. 2020 Sep;81:1-8. doi: 10.1016/j.ijsu.2020.07.032. Epub 2020 Jul 26.

Mortality from COVID-19: are we getting closer to the true value?

Pathog Glob Health. 2020 Oct;114(7):347-348. doi: 10.1080/20477724.2020.1827617. Epub 2020 Oct 4.

Comparison of clinical characteristics of coronavirus disease (COVID-19) and severe acute respiratory syndrome (SARS) as experienced in Taiwan.

Travel Med Infect Dis. 2020 Jul-Aug;36:101625. doi: 10.1016/j.tmaid.2020.101625. Epub 2020 Mar 14.

Origin of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and COVID-19.

Forensic Sci Med Pathol. 2020 Dec;16(4):745. doi: 10.1007/s12024-020-00323-3. Epub 2020 Oct 26.

引用本文的文献

Comparison of corticosteroids types, dexamethasone, and methylprednisolone in patients hospitalized with COVID-19: A systematic review and network meta-analysis.

Glob Epidemiol. 2023 Jul 31;6:100116. doi: 10.1016/j.gloepi.2023.100116. eCollection 2023 Dec.

A Study of the Detection of SARS-CoV-2 by the Use of Electrochemiluminescent Biosensor Based on Asymmetric Polymerase Chain Reaction Amplification Strategy.

IEEE Sens J. 2022 Sep 27;23(8):8094-8100. doi: 10.1109/JSEN.2022.3201507. eCollection 2023 Apr.

Next-generation proteomics of serum extracellular vesicles combined with single-cell RNA sequencing identifies MACROH2A1 associated with refractory COVID-19.

Inflamm Regen. 2022 Nov 30;42(1):53. doi: 10.1186/s41232-022-00243-5.

COVID-19 and the potential of Janus family kinase (JAK) pathway inhibition: A novel treatment strategy.

Front Med (Lausanne). 2022 Aug 30;9:961027. doi: 10.3389/fmed.2022.961027. eCollection 2022.

Cannabis consumption is associated with lower COVID-19 severity among hospitalized patients: a retrospective cohort analysis.

J Cannabis Res. 2022 Aug 5;4(1):46. doi: 10.1186/s42238-022-00152-x.

Ventilator-associated pneumonia in critically ill patients with COVID-19 infection: a narrative review.

ERJ Open Res. 2022 Jul 25;8(3). doi: 10.1183/23120541.00046-2022. eCollection 2022 Jul.

Janus Kinase Signaling Pathway and Its Role in COVID-19 Inflammatory, Vascular, and Thrombotic Manifestations.

Cells. 2022 Jan 17;11(2):306. doi: 10.3390/cells11020306.

Drug delivery systems as immunomodulators for therapy of infectious disease: Relevance to COVID-19.

Adv Drug Deliv Rev. 2021 Nov;178:113848. doi: 10.1016/j.addr.2021.113848. Epub 2021 Jun 25.

Critical care after the COVID-19 outbreak in China: lessons and renaissance.

Intensive Care Med. 2021 Sep;47(9):1017-1020. doi: 10.1007/s00134-021-06447-6. Epub 2021 Jun 22.

Pathological findings in organs and tissues of patients with COVID-19: A systematic review.

PLoS One. 2021 Apr 28;16(4):e0250708. doi: 10.1371/journal.pone.0250708. eCollection 2021.

本文引用的文献

Retraction Note to: SARS-CoV-2 infects T lymphocytes through its spike protein-mediated membrane fusion.

Cell Mol Immunol. 2020 Aug;17(8):894. doi: 10.1038/s41423-020-0498-4.

SARS-CoV-2 Reverse Genetics Reveals a Variable Infection Gradient in the Respiratory Tract.

Cell. 2020 Jul 23;182(2):429-446.e14. doi: 10.1016/j.cell.2020.05.042. Epub 2020 May 27.

Postmortem Examination of Patients With COVID-19.

JAMA. 2020 Jun 23;323(24):2518-2520. doi: 10.1001/jama.2020.8907.

Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19).

Front Immunol. 2020 May 1;11:827. doi: 10.3389/fimmu.2020.00827. eCollection 2020.

Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.

Lancet Respir Med. 2020 Jul;8(7):687-695. doi: 10.1016/S2213-2600(20)30193-4. Epub 2020 May 7.

Time to consider histologic pattern of lung injury to treat critically ill patients with COVID-19 infection.

Intensive Care Med. 2020 Jun;46(6):1124-1126. doi: 10.1007/s00134-020-06057-8. Epub 2020 Apr 23.

Critically ill SARS-CoV-2-infected patients are not stratified as sepsis by the qSOFA.

Ann Intensive Care. 2020 Apr 19;10(1):43. doi: 10.1186/s13613-020-00664-w.

Comparative Replication and Immune Activation Profiles of SARS-CoV-2 and SARS-CoV in Human Lungs: An Ex Vivo Study With Implications for the Pathogenesis of COVID-19.

Clin Infect Dis. 2020 Sep 12;71(6):1400-1409. doi: 10.1093/cid/ciaa410.

Transcriptomic characteristics of bronchoalveolar lavage fluid and peripheral blood mononuclear cells in COVID-19 patients.

Emerg Microbes Infect. 2020 Dec;9(1):761-770. doi: 10.1080/22221751.2020.1747363.

Clinical and immunological features of severe and moderate coronavirus disease 2019.

J Clin Invest. 2020 May 1;130(5):2620-2629. doi: 10.1172/JCI137244.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Pulmonary immune responses against SARS-CoV-2 infection: harmful or not?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献